Side Effects and Safety Side effects Across preclinical studies and the small human trials published to date (~28 subjects across pilot studies), the reported adverse events stay limited: Mild injection-site irritation (rare) No systemic toxicity at therapeutic doses in published reports Oral administration: mild GI upset in sensitive individuals No immunosuppression, hormonal disruption, or metabolic side effects have been observed
Wlaschek, M., Singh, K., Sindrilaru, A., Crisan, D
229 Compared with control mice in the same litter, after 20 min of ischemia and 90 min of reperfusion, the area of cardiac infarction in Sirt5 knockout mice was larger
The storage guidelines printed on peptide vials are written for worst-case pharmaceutical liability
Lifetime alcohol consumption and risk of Barretts esophagus
The ban focuses on peptide hormones, growth factors, and related substances that have performance-enhancing potential or are not approved for human use